Ambulatory thyroidectomy is safe and beneficial in papillary thyroid carcinoma: Randomized controlled trial

Background Currently, no randomized controlled trial has been performed to investigate the safety profiles, economic benefit and mental health of ambulatory thyroidectomy in patients with papillary thyroid carcinoma (PTC). Methods Patients diagnosed with PTC were enrolled in this study and were randomly assigned to ambulatory group and control group. The safety profiles, economic benefit and mental health were investigated. Results Four hundred and eleven patients completed the study. There was no significant difference in demographic or tumor index. The incidence of complications was not significantly different (P = .631). The economic cost was significantly lower (P < .001) and hospitalization was significantly shorter (P < .001) in ambulatory group. No significant difference was shown in depression (P = .758) and stress disorder (P = .390). However, the ambulatory group showed a higher point of anxiety (P < .001). Conclusion The ambulatory thyroidectomy is safe in patients with PTC, with significant benefits of economic cost and hospitalization.

Automated summary

The study found that ambulatory thyroidectomy is safe in patients with PTC, with significant benefits in terms of economic cost and hospitalization. In terms of mental health, the ambulatory group showed a higher level of anxiety, while there was no significant difference in depression and stress disorder.